Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Sansheng Mandy Pharmaceutical is a specialized pharmaceutical company focused on the development, manufacturing, and commercialization of dermatological and external medication products. As a key subsidiary of 3SBio, the company is best known for its market-leading hair regrowth treatment, Mandi (minoxidil tincture), which holds a dominant share of the Chinese over-the-counter hair loss market. Beyond hair health, the company maintains a diverse portfolio of topical treatments for skin conditions such as psoriasis and fungal infections. Mandy Pharmaceutical operates large-scale GMP-certified manufacturing facilities in Hangzhou, supporting both its internal product line and broader corporate production needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Sansheng Mandy Pharmaceutical.